| Document |
Document Title |
|
WO/2005/094878A1 |
It is intended to provide a medicinal composition for transferring a chemotherapeutic agent (preferably an anticancer agent) into a cell or a living body by using a virus envelope vector. For achieving this purpose, a medicinal compositi...
|
|
WO/2005/091754A2 |
Novel compounds and methods useful in the control, treatment, and prevention of fungal activity.
|
|
WO/2005/092877A1 |
The invention relates to glucopyranosyl-substitutedted benzol derivatives of general formula (I), wherein rests R1 to R6 and R7a, R7b, R7c are such as defined in the claim 1, including the tautomers, stereoisomers, mixtures and the salts...
|
|
WO/2005/092908A1 |
The present invention relates to the use of base addition salts of Formula I for treating or preventing airway hyper reactivity and airway inflammation in a mammal. It in turn may also prove a potential benefit in the treatment of Chroni...
|
|
WO/2005/090368A1 |
The invention relates to synthetic molecules that spontaneously and stably incorporate into lipid by-layers, including cell membranes. Particularly, although not exclusively, the invention relates to the use of these molecules as synthet...
|
|
WO/2005/090382A1 |
The present invention relates compounds of the formula (A) oligosaccharide-spacer-GpIIb/IIIa antagonist (A), wherein the oligosaccharide is a negatively charged oligosaccharide residue comprising four to twenty five monosaccharide units,...
|
|
WO/2005/089522A2 |
A method for producing sophorolipids having spermicidal and/or antiviral properties by synthesizing the sophorolipid by fermentation of Candida bombicola in a fermentation media to form a natural mixture of lactonic sophorolipids compoun...
|
|
WO/2005/087843A1 |
The invention relates to a grafted polymer comprising a polyorganosiloxane backbone and gylcoside units. The invention also relates to a method of preparing the polymer and to the use thereof. The invention further relates to an intermed...
|
|
WO/2005/087785A2 |
The invention relates to a non-ionic surfactant and to a method for the alkoxylation of alkyl and/or alkenyl polyglycosides, in addition to the use of said type of accessible compounds as adjuvants in agrochemical formulations.
|
|
WO/2005/085264A1 |
The invention relates to compounds which are polysufated oligosaccharide derivatives having activity as inhibitors of heparan sulfate-binding proteins and inhibitors of the enzyme heparanase; methods for the preparation of the compounds;...
|
|
WO/2005/080549A2 |
The invention relates to the use of trioxacarcins as agents for treating infections caused by fungi, parasites, viruses or bacteria. The invention also relates to the novel trioxacarcin derivatives as such, to drugs containing them or th...
|
|
WO/2005/077965A1 |
A novel ligand composite which is effectively utilizable for analyzing a function of a protein; a ligand-supporting object; and a method of analyzing a protein. The ligand composite has a structure which comprises: a linker compound havi...
|
|
WO/2005/077963A1 |
The invention concerns saccharide and itol derivatives having an O-alkyl group or an O-alkyl group and an O-n butanyl group, uses as medicines in tumoral or benign proliferative pathologies. One of the aims of the present invention is to...
|
|
WO/2005/077964A1 |
The invention relates to derivatives of saccharide and itols having an O-n-alcanoyl group an O-ortho-acetylsalicyloyl group and the uses thereof as food additives or non-food additives or as medicaments. One of the aims of the invention ...
|
|
WO/2005/076743A2 |
The present invention is of a method and compounds for mediating a biological activity mediated by moesin, and in particular, for such a method and compounds for mediating a biological activity that is capable of being mediated through b...
|
|
WO/2005/075491A1 |
The present invention relates to a determination of a stereochemistry, a synthesis and dauer effect of 6R-(3,6-dideoxy-L-arabino-hexopyranosyloxy) heptanoic acid as a pheromone isolated from the Caenorhabditis elegance related to suppres...
|
|
WO/2005/075493A1 |
A glycolipid-containing compound characterized by being represented by the following general formula (1): (1) wherein GN indicates a sugar chain moiety comprising N sugar molecules (N is an integer of 1 to 10) bonded linearly or branch-w...
|
|
WO/2005/075492A1 |
It is intended to provide a remedy for ulcerative colitis by which 5-aminosalicylic acid (5-ASA) useful as a remedy for ulcerative colitis can be efficiently delivered to the affected site (i.e., the large intestine) with little absorpti...
|
|
WO/2005/072765A2 |
A method to synthesize benzyl group protected alpha-pentagalloylglucose (&agr -PGG) and related compounds. The method comprises the steps of: suspending a highly reactive acylation agent and an acylating catalyst in a donor solvent; addi...
|
|
WO/2005/070945A1 |
A compound represented by, e.g., the general formula (I) or a pharmacologically acceptable salt or solvate thereof. They have excellent antibacterial activity against bacteria causative of severe infectious diseases such as pneumonia and...
|
|
WO/2005/066193A1 |
A compound having the excellent function of inhibiting macrophage activity and represented by the following general formula: (I) [wherein Q is oxygen, C1-3 alkylene, -O-Alk-, or -O-Alk-O- (wherein Alk is C1-3 alkylene); R1 is optionally ...
|
|
WO/2005/063263A1 |
The invention relates to novel derivatives of morphine-6-glucuronide, the preparation method thereof and the uses of same in therapy, for example, as analgesics.
|
|
WO/2005/063784A1 |
The present invention relates to synthetic compounds that are active on plants, especially as legume nodulation factors, and also as plant growth stimulators, and to methods for preparing such compounds, which are of formula (I):'Veuille...
|
|
WO/2005/063848A1 |
A modified polyol having alkoxylation and amine capping units, uses of the modified polyol having alkoxylation and amine capping units, and leaning compositions having the modified polyol having alkoxylation and amine capping units.
|
|
WO/2005/063785A2 |
The invention relates to glucopyranosyloxy-substituted aromates of general formula (I), wherein R1 to R6 and R7a, R7b, R7c are defined according to patent claim 1. The invention also relates to the tautomers, stereoisomers, mixtures and ...
|
|
WO/2005/063847A1 |
A modified polyol compound having alkoxylation and having at least one anionic capping unit, uses of the modified polyol compound having alkoxylation and having at least one anionic capping unit and cleaning compositions comprising the s...
|
|
WO/2005/063797A1 |
The present invention provides novel nonnatural C-linked carbo-β-peptides with robust secondary structures, which comprises the synthesis of a new class of β-peptides called C-linked carbo-β-peptides, most of which are favorably dispo...
|
|
WO/2005/062748A2 |
Bicyclic carbohydrates for the treatment of infections caused by herpseviridae, and in particular cytomegalovirus. The invention consists of the novel bicyclic carbohydrates the generic structure of which is formula I: wherein R1 is eith...
|
|
WO/2005/062824A2 |
This invention provides cholesterol absorption inhibitors of formula (I), and the pharmaceutically acceptable salts and esters thereof. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholesterol, and fo...
|
|
WO/2005/061523A1 |
The invention relates to compounds that are designed to mimic the structure of GAGs; methods for the preparation of the compounds; compositions comprising the compounds; and use of the compounds and compositions thereof for the anti-angi...
|
|
WO/2005/060573A2 |
The present invention relates to methods and compositions pertaining to conjugates composed of a peptide nucleic acid (PNA) moiety and a neamine derivative moiety. Methods for using such conjugates for modulating the activity of a target...
|
|
WO/2005/056572A2 |
The present invention provides novel clustered multi-antigenic; constructs having the structure (I) and methods for the synthesis thereof. In still another aspect, the present invention provides methods for the treatment of cancer, prefe...
|
|
WO/2005/054264A2 |
Compounds and methods are provided for modulating in vivo and in vivo processes mediated by selectin biniding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g. inhibi...
|
|
WO/2005/051969A1 |
Various compounds obtained from plants of the Barringtonia species which are derived from Barringtoside A and Barringtoside C as precursor compounds which especially have an arabinopyranosyl substituent at the 21 position which may optio...
|
|
WO/2005/051920A2 |
Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhib...
|
|
WO/2005/049598A1 |
The invention relates to novel hydrosoluble yellow colouring agents of general formula (I), wherein n is equal to 0 or 1, R1 is H or an alkyl group, R2 is H, a glucose group or a xyloglucose group. A method for preparing and using the in...
|
|
WO/2005/049631A1 |
The present invention is directed to synthetic molecules having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosaccharide) activity, for use in the treatment and prevention of inflammatory or immune cel...
|
|
WO/2005/048921A2 |
Novel bicyclic carbohydrate compounds are effective for the prophylaxis and treatment of diseases caused by infections of the alphaherpesvirinae HSV-1 and HSV-2.
|
|
WO/2005/044256A1 |
The instant invention provides novel cholesterol absorption inhibitors of Formula I and the pharmaceutically acceptable salts and esters thereof. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholester...
|
|
WO/2005/042539A1 |
Tocopherol-modified therapeutic drug compounds; emulsion, microemulsion, and micelle formulations that include the compounds; methods for making the compounds and formulations; methods for administering the compounds and formulations; an...
|
|
WO/2005/041983A1 |
The invention relates to a medicament comprising at least one reducing alkyl-sugar monomer having a hydroxyl function which is substituted by an alkoxy radical at C2-C40, said medicament being preferably intended to regulate inflammatory...
|
|
WO/2005/042553A1 |
The invention relates to a method of preparing oligorhamnosides, comprising a one-pot reaction in acetonitrile without any rhamnose protection or deprotection reaction. The invention also relates to a composition comprising a mixture of ...
|
|
WO/2005/037849A1 |
The present invention relates to a process for preparing solidified maltitol. The solidified maltitol is prepared by turbulating a maltitol powder with gas and contacting it with a maltitol containing syrup wherein the quantity of the po...
|
|
WO/2005/037187A2 |
The present invention relates to long branched poly-N-acetyllactosamines and analogous spacer modified divalent sialosides binding to the large binding site of influenza hemagglutinin. The invention further relates to the method for eval...
|
|
WO/2005/037711A1 |
Herein are disclosed substituted fullerenes, comprising a fullerene core (Cn), wherein n is an even integer greater than or equal to 60; 3 or 5 dihydrocarbylmalonate (>C(COOR1)(COOR2)) groups bonded to the fullerene core; and 1 or 3 pola...
|
|
WO/2005/033652A2 |
The invention relates to techniques for measuring and comparing relative molecular flux rates of different biological molecules by administering isotope-labeled water to one or more tissues or individuals and comparing the molecular flux...
|
|
WO/2005/033122A1 |
A process for selectively and easily producing a glycerol glycoside in which the hydroxy group in the 1-position of the glycerol has been glycosylated and which is useful as a glyceroglycolipid precursor, humectant, etc. Provided are: a ...
|
|
WO/2005/033100A1 |
The present invention relates to novel hypocholesterolemic compounds of formula (I) useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels as well as to pharmaceutical compositions comprisin...
|
|
WO/2005/028491A1 |
This invention relate to a Epimeredi Glycoside A of formula 1, and the formulation containing thereof and their preparation method. The formulations are various oral formulations comprising of extracts from. the roots of Epimeredi indica...
|
|
WO/2005/027828A2 |
This invention features a compound of the following formula: T-(-L-C)m, T is a transportophore, L is a bond or a linker having a molecular weight up to 240 dalton, C is a non-antibiotic therapeutic agent, and m is 1, 2, 3, 4, 5, 6, 7, or...
|
